A regenerative pentadecapeptide protocol — small daily injections for short, intentional cycles to support tendon, joint, and gut tissue.
BPC-157 (Body Protection Compound–157) is a synthetic pentadecapeptide — a fifteen-amino-acid sequence derived from a protective peptide first isolated from human gastric juice. In preclinical research it has been studied for its effects on connective tissue, vascular formation, and gut-lining integrity, and it remains an actively researched molecule.
The clinical conversation around BPC-157 is honest about what it is and what it isn't. It is a peptide with a meaningful research record on tissue repair and a relatively clean tolerability profile in the protocols where it's used. It is not a magic-bullet recovery drug, and clinicians who use it well treat it like a tool — applied for specific situations, in defined cycles, with clear intent.
The MyPromise protocol is a small daily subcutaneous injection for four to eight weeks, followed by an intentional break. Cycles can be repeated based on response and clinician judgment. Members typically use it during periods of focused recovery from training, post-injury, or to support gut-related goals as part of a larger plan.
Compounded BPC-157 is dispensed only by accredited 503A U.S. pharmacies under your clinician's order, with each batch tested for potency, sterility, pH, and endotoxins.
Every member's curve is a little different. The shape below is the typical clinician-guided arc.
You begin daily subcutaneous dosing. The first signal for many is reduced soreness or stiffness within seven to ten days.
Your clinician reviews response and tolerance. Some members complete a four-week cycle here; others continue.
Most cycles end here. A planned break of two to four weeks follows before any second cycle.
Your clinician evaluates outcomes. Some members run a second cycle; others have what they need and pause.
BPC-157 isn't for everyone, and we don't pretend otherwise. Your clinician will confirm fit during your eligibility review.
Mild redness or warmth is uncommon and self-resolving. Rotate sites daily and warm the dose to room temperature before injecting.
A faint warm sensation shortly after dosing is reported occasionally and resolves quickly.
Some members report subtle changes in digestion early in a cycle. They typically settle within the first week.
Mild and transient. Hydration usually resolves it. Tell your clinician if persistent.
Billed monthly. Pause or cancel from your dashboard in one click. Final price is set after clinician review and may vary based on dose and protocol.
Take the twelve-minute eligibility review. A licensed clinician will read your intake, recommend a protocol — or tell you honestly that we're not the right fit. Either way, you'll know within a day.